| Bioactivity | Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3]. |
| Invitro | Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells[1]. |
| Name | Terazosin |
| CAS | 63590-64-7 |
| Formula | C19H25N5O4 |
| Molar Mass | 387.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |